AKT1 and non-small cell lung carcinoma: Via TNF-α/nuclear factor kappa B (NF-κB) and phosphatidylinositol 3-kinase (PI3K)/AKT pathways, sotetsuflavone suppresses the migration and invasion of NSCLC cells and may be effective in treating the tumor [35].